Myriad Genetics
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • Affordability
        • Billing
        • Financial assistance
      • Patient Resources
        • Disease information
        • Patient record request
        • Documents & forms
        • Blood draw locator
        • Blog
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Scientific Publications
        • MyRisk® gene table
        • Affordability
        • Financial assistance
        • EMR Integrations
      • Provider resources
        • Order a test kit
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
        • Blood draw locator
        • Blog
        • Webinars & events
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
      • Health Systems
        • Women’s Health
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • FirstGene™
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise Tumor®
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
        • Newsroom
      • (column wrapper)
        • Webinars & events
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Laboratory and Support Center
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640
PORTALS ORDER
    Portals
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • Affordability
        • Billing
        • Financial assistance
      • Patient Resources
        • Disease information
        • Patient record request
        • Documents & forms
        • Blood draw locator
        • Blog
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Scientific Publications
        • MyRisk® gene table
        • Affordability
        • Financial assistance
        • EMR Integrations
      • Provider resources
        • Order a test kit
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
        • Blood draw locator
        • Blog
        • Webinars & events
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
      • Health Systems
        • Women’s Health
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • FirstGene™
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise Tumor®
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
        • Newsroom
      • (column wrapper)
        • Webinars & events
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Laboratory and Support Center
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640

Category: Women’s Health

Women's Health
  • Category
    • All
    • About Myriad Genetics
    • Breast Cancer
    • Carrier screening
    • Colorectal Cancer
    • Corporate
    • Employee Spotlight
    • Equity
    • GeneSight
    • Genetic Counselors
    • Health Systems
    • Hereditary Cancer
    • Infographic for Multimedia page
    • Infographics
    • Lynch Syndrome
    • Melanoma
    • MyRisk
    • Neuroscience
    • Oncology
    • Ovarian Cancer
    • Pancreatic Cancer
    • Patient Blog
    • Patient Story
    • Patient-Featured
    • Precise MRD
    • Prenatal care
    • Prenatal Screening (NIPS)
    • Prequel
    • Prolaris
    • Prostate Cancer
    • Provider
    • Provider Blog
    • Uncategorized
    • Urology
    • Women's Health

One Visit. Lasting Impact. – A MyRisk® Provider Story

November 6, 2025

Physician Assistant Linda New, PA-C, adopted her “every patient, every visit” mantra after an encounter she’ll never forget. Several years ago, ...

Continue Reading

Facing Fear, Finding Strength: Jodi’s Story of Genetic Testing and Prevention

September 4, 2025

Jodi grew up with a fear of cancer from young adulthood. Her mother was diagnosed with breast cancer at the age of 51, and her maternal grandfather was also ...

Continue Reading

5 Ways a Women’s Genetic Testing Provider Should Align with Your Value-Based Care Goals

September 4, 2025

John Oberg, SVP Business Development/Strategy, Myriad Genetics Value-based care is still very much a long-term strategy within large and mid-size health s...

Continue Reading

Genetic Testing in the C-Suite: Five Things Health System Leaders Need to Know Now

September 4, 2025

Melissa Gonzales, President, Women’s Health, Myriad Genetics Although genetic tests and screens have been widely available for more than 30 years now, m...

Continue Reading

The Clinical Impact of Myriad Women’s Health on Hereditary Cancer Risk Assessment and Genetic Testing

September 4, 2025

Gabriel Lazarin, VP Medical Affairs, Women’s Health, Myriad Genetics   Edie Smith, Doctor of Nursing Practice, Senior Medical Science Liaison, ...

Continue Reading

Modernizing Genetic Counseling in Women’s Health Programs: Enhancing Clinical Workflows While Reducing Provider Burden

September 4, 2025

Kaylee Henson, MS, CGC, Senior Product Manager, Pipeline Products, Myriad Genetics Susan Manley, MS, CGC, Senior VP Medical Services, Myriad Genetics ...

Continue Reading

Ten Ways a Genetic Testing Provider Should Help Streamline Women’s Health Medical Management Operations

September 4, 2025

Rent Baxley, Senior Director of Commercial Strategy, Myriad Genetics Every health system is trying to take cost, friction and complexity out of its geneti...

Continue Reading

No Patient Left Behind – A MyRisk Provider Story

February 18, 2025

Dr. Robert Seiler uses the MyRisk® Hereditary Cancer Test because of a personal experience that has become his professional true north. Dr. Seiler lost his de...

Continue Reading

Sports Anchor Hannah Storm Shines Spotlight on the Importance of Genetic Testing 

February 4, 2025

Hannah Storm is a legendary sports journalist, producer and director who has broken barriers in the sports industry. She is also a breast cancer survivor. ...

Continue Reading

Breast Density and Cancer Risk: What You Should Know

October 8, 2024

The latest Cancer Risk Survey: Breast Cancer Edition shows that more than half (63%) of women do not know that breast density is associated with an increased r...

Continue Reading

Recognizing Red Flags for Cancer: The Importance of Early Detection

April 26, 2024

Cancer often begins with subtle warning signs that are easily overlooked. Early detection is key to successful treatment and improved outcomes. Among the vario...

Continue Reading

Dense Breasts, Cancer Prevention and Early Detection

April 26, 2024

Boobs. The Girls. Tatas. Breasts have a lot of names and yet most people have very little understanding of them and how they work, and likely even less underst...

Continue Reading

Rare Diseases: Pathways to accelerating diagnoses 

March 13, 2024

Many of us have seen stories in the news about American families on diagnostic odysseys for their children with rare diseases. Recently, the Today Show highlig...

Continue Reading

A love story interrupted by breast cancer

February 8, 2024

You probably know a few high school sweethearts who are still together after many years. But you probably can’t name as many junior high school sweethea...

Continue Reading

“An individual plan of care”: How MyRisk® with RiskScore® helps one Native American clinic

January 29, 2024

Breast cancer is the second leading cause of cancer death for Native American women, according to the American Indian Cancer Foundation (AICF). Further, t...

Continue Reading
  • 1
  • 2
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Newsroom
    • Blog
  • About
    • About Myriad
    • Careers
    • Contact us
  • Terms of Use
  • HIPAA Notice of Privacy Practices
  • Provider Portal Terms of Use
  • Privacy Notice
  • Patents
  • Health Privacy Notice
  • Compliance and Code of Conduct
  • Notice of Nondiscrimination and Discrimination Grievance Procedure
  • IT Security
  • Notice of Access to Language Assistance Services
  • Cookie Preferences
facebook linkedin x X/Twitter social network instagram youtube
  • © 2025 Myriad Genetics, Inc.

Locations

United States
Europe
Japan